The Development of Scleromalacia after Regional Conjunctivectomy with the Postoperative Application of Mitomycin C as an Adjuvant Therapy.
10.3341/kjo.2013.27.3.208
- Author:
Hye Young SHIN
1
;
Man Soo KIM
;
Sung Kun CHUNG
Author Information
1. Department of Ophthalmology and Visual Science, The Catholic University of Korea College of Medicine, Seoul, Korea. eyedoc@catholic.ac.kr
- Publication Type:Case Reports
- Keywords:
Mitomycin C;
Regional conjunctivectomy;
Scleromalacia
- MeSH:
Adult;
Antibiotics, Antineoplastic/adverse effects;
Conjunctival Diseases/*drug therapy/pathology/*surgery;
Female;
Humans;
Mitomycin/*adverse effects;
Postoperative Complications/*chemically induced/pathology;
Scleral Diseases/*chemically induced/pathology
- From:Korean Journal of Ophthalmology
2013;27(3):208-210
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 40-year-old woman presented with ocular discomfort in both eyes that had persisted for several months. Six months ago, she had undergone a bilateral nasal and temporal conjunctivectomy using a bare scleral technique followed by a postoperative application of 0.02% mitomycin C (MMC) to treat her chronic hyperemic conjunctiva for cosmesis. Slit-lamp examination revealed that the patient had bilateral nasal and temporal scleral thinning, and a calcified plaque on her nasal conjunctiva. There was no episcleral tissue present around the wound area, and it was difficult to detect any normal conjunctival tissue in the adjacent area for covering the lesion. We believe that performing an aggressive conjunctival excision procedure followed with MMC application for cosmetic enhancement may be disastrous in certain cases.
